Spots Global Cancer Trial Database for bendamustine (benda)
Every month we try and update this database with for bendamustine (benda) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma | NCT06191744 | Follicular Lymp... | Epcoritamab Prednisone Rituximab Lenalidomide Doxorubicin Vincristine Cyclophosphamid... Obinutuzumab Bendamustine | 18 Years - | AbbVie | |
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma | NCT06191744 | Follicular Lymp... | Epcoritamab Prednisone Rituximab Lenalidomide Doxorubicin Vincristine Cyclophosphamid... Obinutuzumab Bendamustine | 18 Years - | AbbVie |